RP
LMAT icon

Riverbridge Partners’s LeMaitre Vascular LMAT Stock Holding History

Riverbridge Partners’s Portfolio LMAT Stock Details LMAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.49M Sell
88,467
-17,132
-16% -$1.76M 0.24% 80
2026
Q1 		$11.5M Buy
+105,599
New +$10.1M 0.28% 76

Other funds holding LMAT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Riverbridge Partners's LMAT Position: Q2 2026 in Review

Riverbridge Partners reduced its LeMaitre Vascular (LMAT) stake by 16% in Q2 2026, selling an estimated $1.76M and leaving 88,467 shares worth $8.49M. The position accounts for 0.24% of the portfolio, ranked #80.

Riverbridge Partners first reported a position in LMAT in Q1 2026 and has held it in 2 quarters since. The position peaked at $11.5M in Q1 2026. 326 funds tracked by Wall St. Rank hold LMAT as of Q2 2026.

  • Riverbridge Partners held 88,467 shares of LeMaitre Vascular worth $8.49M as of Q2 2026.
  • Riverbridge Partners sold 17,132 LeMaitre Vascular shares in Q2 2026, an estimated $1.76M.
  • LeMaitre Vascular made up 0.24% of Riverbridge Partners's portfolio in Q2 2026, its #80 holding.
  • Riverbridge Partners first reported a position in LeMaitre Vascular in Q1 2026 and has held it in 2 quarters since.
  • Riverbridge Partners's LeMaitre Vascular position peaked at $11.5M in Q1 2026.
  • 326 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2026.

Based on Riverbridge Partners's 13F filing for Q2 2026, filed 13 Jul 2026.